StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note published on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of SRNE stock opened at $0.00 on Monday. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25. The stock has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.
Sorrento Therapeutics Company Profile
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- How Can Investors Benefit From After-Hours Trading
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- What are earnings reports?
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.